Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

URL

https://academic.oup.com/cid/article/75/1/e545/6563799

Authors

Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Esma Herzel, Hillel Alapi, Dani Cohen, Khitam Muhsen, Gabriel Chodick, and Tal Patalon

Published Date

April 5, 2022

Publication

Clinical Infectious Diseases

Organization

Maccabi Healthcare Services (Israel)

Medium

document

Topics

adverse events,at risk populations,clinical cases,COVID-19,health statistics,pre-existing conditions risk factor,prior conditions relapse,risk factors,vaccine (or viral) immune escape (VIE),vaccines